//
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Functional Impairment and Medication Burden in Adults With Heart Failure
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification
Lifestyle Modifications for Preventing and Treating Heart Failure